MIRA Pharmaceuticals files exhibit document with SEC
Mira Pharmaceuticals submitted an exhibit filing (EX-10.1) with the SEC. The specific content and market impact cannot be determined from the limited document header provided.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day